Cargando…
Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1
Vaccines are one of the greatest medical accomplishments to date, yet no fungal vaccines are currently available in humans mainly because opportunistic mycoses generally occur during immunodeficiencies necessary for vaccine protection. In previous studies, a live, attenuated Cryptococcus neoformans...
Autores principales: | Normile, Tyler G., Del Poeta, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124966/ https://www.ncbi.nlm.nih.gov/pubmed/35615354 http://dx.doi.org/10.3389/fimmu.2022.868523 |
Ejemplares similares
-
Cryptococcus neoformans Δsgl1 Vaccination Requires Either CD4(+) or CD8(+) T Cells for Complete Host Protection
por: Normile, Tyler G., et al.
Publicado: (2021) -
Vaccine protection by Cryptococcus neoformans Δsgl1 is mediated by γδ T cells via TLR2 signaling
por: Normile, Tyler G., et al.
Publicado: (2022) -
Vaccination with Live or Heat-Killed Aspergillus fumigatus ΔsglA Conidia Fully Protects Immunocompromised Mice from Invasive Aspergillosis
por: Fernandes, Caroline Mota, et al.
Publicado: (2022) -
Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development
por: Rella, Antonella, et al.
Publicado: (2015) -
Cryptococcus Neoformans Modulates Extracellular Killing by Neutrophils
por: Qureshi, Asfia, et al.
Publicado: (2011)